• Overview
  • Eligibility
  • More info
  • Locations

Palliation of Dyspnea With Mouth Piece Ventilation in Acute Exacerbation of COPD Without Respiratory Insufficiency (NCT03025425)

An uncontrolled feasibility study on using mouth piece ventilation in palliation of dyspnea in subjects with acute exacerbation of COPD without acute hypercapnic respiratory failure. Subjects are recruited from the local respiratory ward. The main outcomes are the compliance of the subjects with the treatment and alleviation of dyspnea during the treatment period.
  • Device: Trilogy 100 ® (Philips Respironics)
    Mouth piece Ventilation (MPV) using Trilogy 100 ® (Philips Respironics).
    Ages eligible for Study
    18 Years and older
    Genders eligible for Study
    Accepts Healthy Volunteers
    Inclusion Criteria:
    • a previous diagnosis of COPD
    • hospitalized due to acute exacerbation of COPD
    • at least moderate dyspnea (NRS = Numeric Rating Scale ≥ 4)
    • no acute hypoventilation (pH ≥ 7.35 and PCO2 ≤ 6.0 kPa)
    • able to understand the study and to give informed consent
    Exclusion Criteria:
    • unable to participate and use MPV due to e.g. delirium or lack of co-operation
    • acute hypoventilation (pH < 7.35 or PCO2 > 6.0 kPa)
    • acute need for ventilatory support
    • the cause of the dyspnea can be successfully treated
    • unable to give informed consent
    • a previous chronic hypoxemic or hypercapnic respiratory insufficiency that has been treated on a long-term basis also at home

    1 locations

    Finland (1)
    • Dpt of Respiratory Medicine, Tampere University Hospital
      Tampere, Finland, 33520
    31 December, 2016
    18 January, 2017
    A girl giving information about available additional trials.

    FindMeCure helps you find, understand and join clinical trials from all over the world.

    There are more clinical trials for your condition!